European Medicines Agency update on Diane 35 and generics used in the treatment of acne (EMA press release, 30 January 2013)

The European Medicines Agency (EMA) has issued an update on the use of Diane 35 and its generics pending a Europe-wide review by the EMA's Pharmacovigilance Risk Assessment Committee, due for publication next week.

EMA press release